18 days ago
IFRX
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 4%
#206 out of 5115 analysts
Average Return
+21.29%
Win Rate
58%79 out of 136
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Phathom Pharmaceuticals IncPHAT | +449.64% | $2.76 | $15.17 | 2025-05-01 - 2025-11-26 | Strong Buy |
Zenas Biopharma IncZBIO | +393.67% | $8.21 | $40.53 | 2025-03-11 - 2025-11-26 | Strong Buy |
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-18 - 2023-09-25 | Strong Buy |
Zura Bio LtdZURA | +184.64% | $1.34 | $3.80 | 2025-03-25 - 2025-11-26 | Strong Buy |
Anaptysbio IncANAB | +180.69% | $15.02 | $42.16 | 2024-12-11 - 2025-11-26 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
a month ago
PRAX
2 months ago
ABVX
2 months ago
ACET
2 months ago
ROIV
4 months ago
NBIX
4 months ago
ARGX
4 months ago
ABVX
a year ago
ARGX
a year ago
SYRE
2 years ago
CLDX
2 years ago
AXSM
2 years ago
LBPH
2 years ago
ARGX
2 years ago
ARGX
3 years ago
LRMR
3 years ago
RXDX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inflarx NvIFRX | 4 | Strong Buy | $22.00 | +1,748.74% | Maintains | 18 days ago |
Anaptysbio IncANAB | 10 | Strong Buy | $100.00 | +137.19% | Maintains | 23 days ago |
Axsome Therapeutics IncAXSM | 8 | Strong Buy | $205.00 | +35.78% | Maintains | 24 days ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $865.00 | +10.25% | Maintains | a month ago |
Neumora Therapeutics IncNMRA | 2 | Strong Buy | $14.00 | +511.35% | Upgrades | a month ago |
Rapt Therapeutics IncRAPT | 3 | Strong Buy | $70.00 | +147.52% | Initiates Coverage On | a month ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $60.00 | +96.98% | Initiates Coverage On | a month ago |
Praxis Precision Medicines IncPRAX | 3 | Strong Buy | $350.00 | +85.64% | Maintains | a month ago |
Abivax SaABVX | 3 | Strong Buy | $150.00 | +19.35% | Maintains | 2 months ago |
Adicet Bio IncACET | 3 | Strong Buy | $8.00 | +1,231.11% | Maintains | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $20.00 | +44.93% | Maintains | 2 months ago |
Argenx SeARGX | 11 | Strong Buy | $1,070.00 | +16.60% | Reiterates | 2 months ago |
Roivant Sciences LtdROIV | 3 | Strong Buy | $21.00 | +0.62% | Maintains | 2 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 3 months ago |
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $100.00 | +127.12% | Maintains | 3 months ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | +293.08% | Initiates Coverage On | 3 months ago |
Cabaletta Bio IncCABA | 6 | Strong Buy | $15.00 | +532.91% | Maintains | 4 months ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $175.00 | +15.45% | Maintains | 4 months ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | +636.54% | Reiterates | 5 months ago |
Alumis IncALMS | 2 | Strong Buy | $18.00 | +135.60% | Reinstates | 6 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | +96.61% | Maintains | 7 months ago |
Phathom Pharmaceuticals IncPHAT | 3 | Strong Buy | $12.00 | -20.90% | Maintains | 7 months ago |
Zura Bio LtdZURA | 2 | Strong Buy | $15.00 | +294.74% | Reiterates | 8 months ago |
Zenas Biopharma IncZBIO | 2 | Strong Buy | $45.00 | +11.03% | Reiterates | 9 months ago |
Immunovant IncIMVT | 4 | Strong Buy | $44.00 | +85.65% | Maintains | 10 months ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | +173.64% | Upgrades | a year ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | a year ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 2 years ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $736.00 | N/A | Maintains | 3 years ago |
Biogen IncBIIB | 3 | Strong Buy | $350.00 | N/A | Upgrades | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 3 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Climb Bio IncCLYM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 7 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.